Published Date: 08 Mar 2023
The White House said Friday it was "dangerous and unacceptable" for elected officials to target women's access to federally-approved abortion pills.
Read Full NewsResearchers compare enzalutamide vs abiraterone in the metastatic castration-sensitive prostate cancer setting.
A new study assesses breast and ovarian cancer risk in women who carry a BRCA variant of uncertain significance or have a noninformative negative result.
1.
Can the way we talk about cancer change how we interact with the disease?
2.
Researchers discover that children who survive cancer have socioeconomic challenges.
3.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
4.
Some low-grade prostate cancers carry higher risks than biopsy suggests
5.
For cancer patients who are not responding to chemotherapy, new genes and natural toxins offer hope.
1.
Clinical Analysis of Prostate Cancer
2.
Metabolic Tumor Risk Profiling Through Preventive Oncology Screening
3.
Patient-Centric Approaches in Hematology: Integrating Individualized Care into Modern Clinical Practice
4.
The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025
5.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
2.
From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD
3.
Navigating the Complexities of Ph Negative ALL - Part VI
4.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
5.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation